Home  |  News  

“What we need to do is get to work on the things that NEHI is talking about, to find out what really works.”

– Timothy Murphy, health care advisor to Mitt Romney campaign, at October 2007 NEHI event

Publications

Medical Innovation


Comparative Effectiveness Research Backgrounder

Publication Date: July 21, 2008
A summary of NEHI's work in comparative effectiveness research.

Fast Adoption of Significant Technologies (FAST) One Page Summary

Publication Date: January 1, 2008
A joint partnership of NEHI, the Massachusetts Technology Collaborative and the Health Technology Center, FAST identifies and rates high-potential, underused medical technologies according to the patient population served, impact on outcomes, potential cost savings and barriers to adoption. By directing spending at high value areas, FAST is improving health care delivery and helping private payers make informed coverage decisions.

Tele-ICUs: Remote Management in Intensive Care Units

Publication Date: March 1, 2007
Tele-ICUs address the shortage in supply of intensivists in intensive care units (ICUs) by enabling a relatively small number of intensivists to oversee the care of a large number of ICU patients.

Challenges in Vaccine Policy: A Case Study of the HPV Vaccine

Publication Date: August 29, 2006
The HPV vaccine's immense promise in preventing cervical cancer -- and the barriers to its widespread adoption -- make it an ideal vehicle for implementing important improvements to the U.S. immunization system.

Continuous Glucose Monitoring: Innovation in the Management of Diabetes

Publication Date: March 1, 2005
CGM devices have potential to be highly valuable and cost-effective tools in managing diabetes.

Remote Physiological Monitoring: Innovation in the Management of Heart Failure

Publication Date: July 1, 2004
RPM provides substantial benefits to the health care system by reducing the number of hospital visits, length of stay and health care costs -- while improving quality of life -- for heart failure patients.

Targeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia

Publication Date: March 1, 2004
The adoption of Gleevec, a pioneering drug in the treatment of CML, highlights challenges and opportunities in bringing drugs treating rare diseases to market.

 
Back To Publications